Liu H - Search Results

1

A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis.

She Q, Chen Y, Liu H, Tan J, Li Y. She Q, et al. Among authors: liu h. Bioengineered. 2022 May;13(5):13437-13451. doi: 10.1080/21655979.2022.2074108. Bioengineered. 2022. PMID: 36700469 Free PMC article.

2

RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway.

Huang Z, Lou K, Qi M, Wang J, Li L, Sun B, Wang C, Zhou X, Chen D, Liu H. Huang Z, et al. Among authors: liu h. J Transl Med. 2024 Nov 22;22(1):1052. doi: 10.1186/s12967-024-05828-x. J Transl Med. 2024. PMID: 39574120 Free PMC article.

3

A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.

Huang Z, Lou K, Liu H. Huang Z, et al. Among authors: liu h. Front Genet. 2022 Oct 13;13:1030275. doi: 10.3389/fgene.2022.1030275. eCollection 2022. Front Genet. 2022. PMID: 36313442 Free PMC article.

4

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.

Liu Y, Hong G, Mao L, Su Z, Liu T, Liu H. Liu Y, et al. Among authors: liu h, liu t. Molecules. 2023 Apr 23;28(9):3662. doi: 10.3390/molecules28093662. Molecules. 2023. PMID: 37175072 Free PMC article.

5

Neutrophil extracellular trap-associated risk index for predicting outcomes and response to Wnt signaling inhibitors in triple-negative breast cancer.

Huang Z, Wang J, Sun B, Qi M, Gao S, Liu H. Huang Z, et al. Among authors: liu h. Sci Rep. 2024 Feb 20;14(1):4232. doi: 10.1038/s41598-024-54888-y. Sci Rep. 2024. PMID: 38379084 Free PMC article.

6

CD93 regulates breast cancer growth and vasculogenic mimicry through the PI3K/AKT/SP2 signaling pathway activated by integrin β1.

Liu H, Zhang J, Zhao Y, Fan Z, Yang Y, Mao Y, Yang J, Ma S. Liu H, et al. J Biochem Mol Toxicol. 2024 Apr;38(4):e23688. doi: 10.1002/jbt.23688. J Biochem Mol Toxicol. 2024. PMID: 38511888

7

Multi-omics pan-cancer analysis reveals the prognostic values and immunological functions of PPA2, with a spotlight on breast cancer.

Zhang JN, Yang BB, Li LW, Xu H, Wang B, Yi ZL, Zhou XR, Liu H. Zhang JN, et al. Among authors: liu h. Front Immunol. 2024 Aug 8;15:1435502. doi: 10.3389/fimmu.2024.1435502. eCollection 2024. Front Immunol. 2024. PMID: 39176095 Free PMC article.

8

Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway.

Wang N, Fang Y, Hou Y, Cheng D, Dressler EV, Wang H, Wang J, Wang G, Li Y, Liu H, Xiang R, Yang S, Sun P. Wang N, et al. Among authors: liu h. Cell Commun Signal. 2024 Oct 7;22(1):478. doi: 10.1186/s12964-024-01861-x. Cell Commun Signal. 2024. PMID: 39375718 Free PMC article.

9

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study.

Li Y, Wang S, Yang W, Liu H. Li Y, et al. Among authors: liu h. Medicine (Baltimore). 2021 Jul 9;100(27):e26619. doi: 10.1097/MD.0000000000026619. Medicine (Baltimore). 2021. PMID: 34232220 Free PMC article.

10

The Construction of a New Prognostic Model of Breast Cancer and the Exploration of Drug Sensitivity Based on Machine Learning for Glycosylation-Related Genes.

Zhang JN, Zhou XR, Yi ZL, Tian XY, Liu H. Zhang JN, et al. Among authors: liu h. Clin Breast Cancer. 2025 May 10:S1526-8209(25)00117-X. doi: 10.1016/j.clbc.2025.05.004. Online ahead of print. Clin Breast Cancer. 2025. PMID: 40473526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103,062 results

Search Page

Filters